Partner Hospitals

Founded in 1997, it is one of China’s leading private hospital groups. It has established 11 hospitals and 14 clinics in Hong Kong, Beijing, Shanghai, Guangzhou, Shenzhen, Tianjin, Qingdao and other cities. The annual number of patients served exceeds one million, including nearly 100,000 foreign patients. It has built a sizable international medical service network and formed a tiered medical service system of “general hospitals + specialized medical centers + clinics”. It covers a complete medical service chain including family medicine, emergency medicine, women’s health, pediatrics, cardiovascular and cerebrovascular diseases, oncology, urology, gastroenterology, orthopedics, critical care medicine and neuroscience center.

It has 7 national key experimental platforms represented by the State Key Laboratory of Kidney Diseases. The hospital is equipped with nearly 60,000 sets of sophisticated medical equipment worth nearly 7 billion RMB, including the world-leading 5th-generation CyberKnife, Da Vinci surgical robot, digital angiography machine, cyclotron, the world’s second ZAP accelerator, computed tomography therapy system, hyperbaric oxygen chamber, magnetic navigation interventional system, intraoperative radiotherapy system and cobalt-60 therapy unit.

Founded in 1869, the hospital has set national benchmarks including the “Hangzhou Protocol” for transcatheter heart valve replacement, minimally invasive complex cataract surgery, standardized diagnosis and treatment of colorectal tumors, and mass severe trauma rescue. The perioperative survival rate of pediatric liver transplantation is at the internationally leading level.

Founded in 1947, it enjoys a high reputation in organ transplantation, infectious diseases, hematological diseases, kidney diseases, urinary system diseases and clinical pharmacy. It is one of China’s medical centers with the most complete range of large organ transplantation procedures.

Founded in 1964, it is a benchmark for cancer diagnosis and treatment in South China. Annual outpatient and emergency visits reach 2.558 million, and annual inpatient admissions are 222,000. Its medical volume ranks among the top of national oncology-specialized hospitals. It boasts leading medical technologies and an Asia-class radiotherapy center with top-tier hardware and software. Minimally invasive robotic surgeries are performed in multiple specialties. The hospital maintains cooperation with The University of Texas MD Anderson Cancer Center, which ranks No.1 among oncology centers in the United States.

Founded in 1892, it has reached leading domestic and international standards in many fields, such as adult living donor liver transplantation, early diagnosis and treatment of lung cancer, cardiac interventional therapy, neurosurgery and functional neurosurgery, integrated traditional Chinese and Western medicine for severe pancreatitis, and allogeneic combined larynx-trachea-thyroid transplantation.

Founded in 1958. It takes a leading position in China in the fields of early tumor screening, precision radiotherapy, targeted therapy and immunotherapy. Equipped with advanced facilities such as PET-CT, CyberKnife and proton therapy system as well as a multidisciplinary consultation system. The hospital has 72 departments and 626 physicians. Annual outpatient visits exceed 1 million, with more than 30,000 surgeries performed each year.